The biologic function of PML and its role in acute promyelocytic leukemia

Leukemia and Lymphoma

Volumn 23, Issue 3-4, 1996, Pages 277-285

  Mu, Zhao Mei ^a   Le, Xiao Feng ^a   Glassman, Armand B ^a   Chang, Kun Sang ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute promyelocytic leukemia; Pathogenesis; PML growth suppressor; PML oncogenic domain; PML RAR fusion protein

Indexed keywords

HYBRID PROTEIN; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL GROWTH; CELL NUCLEUS MATRIX; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION 15; CLONOGENESIS; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030462983     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054830     Document Type: Review

References (55)

1. Borrow, J., Goddard, A. D., Sheer, D. and Solomon, E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249, 1577-1580.
2. de The, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature, 347, 558-561.
3. Longo, L., Pandolfi, P. P., Biondi, A., Rambaldi, A , Mencarelli, A , LoCoco, F., Diverio, D., Pegoraro, L., Avanzi, G., Tabilio, A., Zangrilli, D., Alcalay, M., Donti, E., Grignani, F. and Pelicci, P. G. (1990) Rearrangements and aberrant expression of the RARα gene in acute promyelocytic leukemias. J. Exp. Med., 172, 1571-1575.
4. Chang, K. S., Stass, S A., Chu, D. T., Deaven, L. L , Trujillo, J. M. and Freireich, E. J. (1992) Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol. Cell. Biol., 12, 800-810.
5. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991) The PML-RARA fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
6. Goddard, A., Borrow, J., Freemont, P. S. and Solomon, E. (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science, 24, 1371-1374.
7. Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P , Frankel, S R., Murry, V. V. V. S., Dmitrovsky, E. and Evans, R. M. (1991) Chromosomal transiocation t(15;17) in human acute promyelocytic leukemia fuses RARA with a novel putative transcription factor, PML. Cell, 66, 663-674.
8. Kastner, P., Perez, A., Lutz, Y Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Structure, localization, and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J., 11, 629-642.
9. Pandolfi, P. P , Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., LoCoco, F. and Pelicci, P. G. (1991) Structure and origin of the acute promyelocytic leukemia myl/RARA cDNA and characterization of its retinoic-binding and transactivation properties. Oncogene., 6, 1285-1292.
10. Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I. and Pelicci, P. G. (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor ceils. Cell, 74, 423-431.
11. Huang, M., Ye, Y. C., Chen, B. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu, L. J. and Wang, Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
12. Castaigne, S , Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P and Degos, L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76, 1704-1709.
13. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M. T., Fenaux, P., Castaigne, S. and Degos, L. (1990) All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood, 76, 1710-1717.
14. Warrell, R. P., Frankel, S. P., Miller, W. H., Scheiberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreef, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. S. and Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med., 324, 1385-1393.
15. Chen, S., Zhu, Y., Tong, J., Dong, S., Huang, W., Chen, Y., Ziang, W., Zhang, L , Li, X., Qian, G., Wang, Z., Chen, Z., Larsen, C. and Berger, R. (1991) Rearrangement in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular markers for retinoic acid-induced leukemia cell differentiation. Blood, 79, 2696-2701.
16. Dyck, J. A., Maul, G. G , Miller, W. H., Chen, J. D., Kakizuka, A. and Evans, R. M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. (1994) Cell, 76, 333-343.
17. Weis, K., Ramboud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell, 76, 345-356.
18. Perez, A., Kastner, P., Sethi S , Lutz, Y., Reibel, C. and Chambon, P. (1993) PML-RAR homodimers: distinct DNA binding properties and heteromeric interaction with RXR. EMBO J., 12, 3171-3182.
19. Koken, M. H. M., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., Jong, L., Szoslecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E. and de The, H. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid reversible fashion. EMBO J., 13, 1073-1083.
20. Freemom, P. S., Hanson, I. M. and Trowsdale, J. (1991) A novel cysteine-rich sequence motif. Cell, 64, 483-484.
21. Reddy, B. A., Etkin, L. D. and Freemont, P. S. (1992) A novel finger coiled-coil domain in a family of nuclear proteins. TIBS, 17, 344-345.
22. Borden, K. L. B., Boddy, M. N., Lally, J., O'Reilly, N. J. and Freemont, P. S (1995) The solution structure of the RING finger domain from the acute promyelocytic leukemia proto-oncogene PML EMBO J., 14, 461-472.
23. Mu, Z-M., Chin, K-V., Liu, J-H., Lozano, G. and Chang, K. S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. (1994) Mol. Cell Biol., 14, 6858-6867.
24. Liu, J. H., Mu, Z. M. and Chang, K. S. (1995) PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181, 1965-1973.
25. Koken, M. H. N., Linares-Cruz, G , Quignon, F., Viron, A., Chelbi-Alix, M. K , Sobczak-Thepot, J., Juhlin, L., Degos, L., Calvo, A. and de The H. (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene, 10, 1316-1324.
26. Ahn, M. J , Nason-Burchenal, K., Moasser, M. M. and Dmitrovsky, E. (1995) Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RARα or PML. Oncogene, 10, 2307-2314.
27. Xie, K., Lambie, E J. and Snyder, M. (1993) Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol , 13, 6170-6179.
28. Freemont, P. S. (1993) Zinc-finger proteins in oncogenesis. Sluyser, M., Geent, A. B., Brinkmann, A. O. and Blankenstein, R. A., (eds.). The New York Academy of Sciences: New York, pp. 174-192.
29. 1H-nuclear magnetic resonance spectroscopy: a new structural class of zinc-finger. J. Mol. Biol., 237, 201-211.
30. Perry, L. J., Rixon, F., Everett, R. D., Frame, M. C. and Mcgeoch, D. J. (1986) Characterization of the IE110 gene of herpes simplex virus type I. J. Gen. Virol., 67, 2365-2380.
31. Ben-Chetrit, E., Chan, E., Sullivan, K. and Tan, E. (1988) A 52K protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med., 167, 1560-1571.
32. Van Lohuizen, M., Frasch, M., Wientjens, E. and Berns, A. (1991) Sequence similarity between the mammalian bmi-1 proto-oncoaene and the Drosophila regulatory genes Psc and Su(z)2. Nature, 353, 353-356.
33. Padykula, H. A. and Clark, J. H. (1981) Nuclear bodies as functional indicators in the target cells of sex steroid hormones. Cell Nucleus, 9, 309-339.
34. Brasch, K. and Ochs, R. L. (1992) Nuclear bodies (NBs): a newly "rediscovered" organelle Exp. Cell. Res., 202, 211-223.
35. Le, X. F., Yang, P. and Chang, K. S. (1996) Analysis of the growth and transformation suppressor domains of PML. J. Biol. Chem., 271, 130-135.
36. Chang, K. S., Fan, Y. H., Andreeff, M., Liu, J. and Mu, Z. M. (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood, 85, 3646-3653.
37. Maul, G. G., Gulder, H. H. and Spivack, J. G. (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICPO). J, Gen. Virol., 74, 2679-2690.
38. Everett, R. D. and Maul, G. G. (1994) HSV-1 IE protein Vmw 110 causes redistribution of PML. EMBO J., 13, 502-5069.
39. Carvalho, T., Seelwe, J. S., Ohman, K., Jordan, P., Pettersson, U., Akusjarvi, G., Carmo-Fonseca, M. and Dejean, A. (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol., 131, 45-56.
40. Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Pandolfi, P. P., Pelicci, P. G. and Dejean, A. (1995) The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene, 11, 871-876.
41. Flenghi, L., Fagioli, M., Tomassoni, L., Pileri, S., Gambacorta, M., Pacini, R., Grignani, F., Casini, T., Ferrucci, P. F., Martelli, M. F., Pelicci, P. G. and Fatini, B. (1995) Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood, 85, 1871-1880.
42. Ascoli, C. A. and Maul, G. G. (1991) Identification of a novel nuclear domain. J. Cell Biol., 112, 785-795.
43. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P. P., Donti, E . Andrea, B., Coco, F. L., Grignani, F. and Pelicci, P. G. (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood, 83, 10-25.
44. Ewen, M. E. (1994) The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev., 13, 45-66.
45. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
46. Isomura, T., Tamiya-Koizumi, K., Suzuki, M., Yoshida, S., Taniguchi, M., Matsuyama, M., Ishigaki, T., Sukuma, S. and Takahashi, M. (1992) RFP is a DNA binding protein associated with the nuclear matrix. Nucleic Acids Res., 20, 5305-5310.
47. Stuurman, N., De Graaf, A., Fioore, A., Josso, A., Humbel, B., De Jong, L. and Van Driel, R. (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci , 101, 773-184.
48. Terris, B., Baldin, V., Dubois, S., Degatt, C., Flejou, J. F. and Henin, D. (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55, 1590-1597.
49. Grignani, F., Testa, U., Fagioli, M., Barberi, T., Masciulli, R., Mariani, G., Cesare, P. and Pelicci, P G. (1995) Promyelocytic leukemia-specific PML-retinoic acid-α receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Cancer Res., 55, 440-443.
50. Testa, U., Grignani, F., Barberi, T., Fagioli, M., Masciulli, R., Ferrucci, P. F., Seripa, D., Camagna, A., Alcalay, M., Pelicci, P. G. and Peschle, C. (1994) PML/RARα+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Res., 54, 4508-4515.
51. Hunter, T. (1991) Cooperation between oncogenes. Cell, 64, 249-257.
52. Weinberg, R. A. (1989) Oncogenes and multistep carcinogenesis, In Oncogenes and the Molecular Origins of Cancer, edited by R. Weinberg, pp. 307-326, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory press
53. Longo, L , Trecca, D., Biondi, A., LoCoco, F., Grignani, F., Maiolo, M. A , Pelicci, P. G. and Neri, A. (1993) Frequency of RAS and p53 mutations in acute promyelocytic leukemia. Leuk. Lymphoma, 11, 405-410.
54. Yamamoto, K., Hirosawa, S., Sakamaki, H. and Aoki, N. (1992) Frequent rearrangements of retinoic acid receptor alpha gene and myl gene, and rare mutations of RAS and FMS genes in acute promyelocytic leukemia Am. J. Hematol., 40, 252-258.
55. Tsai, S. and Collins, S. J. (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc. Natl. Acad. Sci. USA, 90, 7153-7157.